CN103091286A - 疟原虫感染的红细胞的识别方法及装置 - Google Patents
疟原虫感染的红细胞的识别方法及装置 Download PDFInfo
- Publication number
- CN103091286A CN103091286A CN2011103377078A CN201110337707A CN103091286A CN 103091286 A CN103091286 A CN 103091286A CN 2011103377078 A CN2011103377078 A CN 2011103377078A CN 201110337707 A CN201110337707 A CN 201110337707A CN 103091286 A CN103091286 A CN 103091286A
- Authority
- CN
- China
- Prior art keywords
- cell
- plasmodium
- infected
- scatter diagram
- signal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000224016 Plasmodium Species 0.000 title claims abstract description 106
- 238000000034 method Methods 0.000 title claims abstract description 70
- 210000003743 erythrocyte Anatomy 0.000 title claims abstract description 58
- 210000004027 cell Anatomy 0.000 claims abstract description 112
- 238000010586 diagram Methods 0.000 claims abstract description 105
- 210000004369 blood Anatomy 0.000 claims description 69
- 239000008280 blood Substances 0.000 claims description 69
- 238000009534 blood test Methods 0.000 claims description 22
- 238000012545 processing Methods 0.000 claims description 13
- 102000001554 Hemoglobins Human genes 0.000 claims description 11
- 108010054147 Hemoglobins Proteins 0.000 claims description 11
- 230000002159 abnormal effect Effects 0.000 claims description 8
- 230000005859 cell recognition Effects 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 5
- 238000009792 diffusion process Methods 0.000 abstract 6
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000003219 hemolytic agent Substances 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- -1 preferably Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000007421 fluorometric assay Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
- G01N21/51—Scattering, i.e. diffuse reflection within a body or fluid inside a container, e.g. in an ampoule
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/011—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells with lysing, e.g. of erythrocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/012—Red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/016—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N2021/4704—Angular selective
- G01N2021/4707—Forward scatter; Low angle scatter
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N2021/4704—Angular selective
- G01N2021/4711—Multiangle measurement
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N2021/4704—Angular selective
- G01N2021/4726—Detecting scatter at 90°
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N2021/6491—Measuring fluorescence and transmission; Correcting inner filter effect
- G01N2021/6493—Measuring fluorescence and transmission; Correcting inner filter effect by alternating fluorescence/transmission or fluorescence/reflection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
- G01N2333/445—Plasmodium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Physiology (AREA)
- Ecology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (19)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110337707.8A CN103091286B (zh) | 2011-10-31 | 2011-10-31 | 疟原虫感染的红细胞的识别方法及装置 |
PCT/CN2012/083864 WO2013064078A1 (zh) | 2011-10-31 | 2012-10-31 | 疟原虫感染的红细胞的识别方法及装置 |
US14/355,544 US10656143B2 (en) | 2011-10-31 | 2012-10-31 | Methods and apparatuses for identifying red blood cells infected by plasmodium |
US16/814,846 US20200209224A1 (en) | 2011-10-31 | 2020-03-10 | Methods and apparatuses for identifying red blood cells infected by plasmodium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110337707.8A CN103091286B (zh) | 2011-10-31 | 2011-10-31 | 疟原虫感染的红细胞的识别方法及装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103091286A true CN103091286A (zh) | 2013-05-08 |
CN103091286B CN103091286B (zh) | 2016-08-17 |
Family
ID=48191343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110337707.8A Active CN103091286B (zh) | 2011-10-31 | 2011-10-31 | 疟原虫感染的红细胞的识别方法及装置 |
Country Status (3)
Country | Link |
---|---|
US (2) | US10656143B2 (zh) |
CN (1) | CN103091286B (zh) |
WO (1) | WO2013064078A1 (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104297135A (zh) * | 2013-07-16 | 2015-01-21 | 成都深迈瑞医疗电子技术研究院有限公司 | 血液样本中粒子的识别方法、系统及血液细胞分析仪 |
CN104422646A (zh) * | 2013-08-30 | 2015-03-18 | 希森美康株式会社 | 样本分析方法及样本分析装置 |
CN104515723A (zh) * | 2013-09-30 | 2015-04-15 | 深圳迈瑞生物医疗电子股份有限公司 | 细胞分析仪及其红细胞凝集报警方法和系统 |
CN105372216A (zh) * | 2014-08-08 | 2016-03-02 | 希森美康株式会社 | 血液分析方法及血液分析装置 |
CN106483109A (zh) * | 2015-08-31 | 2017-03-08 | 希森美康株式会社 | 血液分析装置及血液分析方法 |
CN108226127A (zh) * | 2017-12-26 | 2018-06-29 | 深圳国际旅行卫生保健中心 | 测定疟原虫含量的方法和检测疟原虫含量的系统 |
CN109580550A (zh) * | 2018-12-03 | 2019-04-05 | 迪瑞医疗科技股份有限公司 | 一种白细胞的分类处理方法及其装置 |
CN110244032A (zh) * | 2015-02-12 | 2019-09-17 | 深圳迈瑞生物医疗电子股份有限公司 | 细胞分析仪及细胞分析仪的分类方法 |
CN113330311A (zh) * | 2019-12-31 | 2021-08-31 | 深圳迈瑞生物医疗电子股份有限公司 | 细胞图像分析装置和样本分析方法 |
WO2022115982A1 (zh) * | 2020-12-01 | 2022-06-09 | 深圳迈瑞生物医疗电子股份有限公司 | 样本分析方法、样本分析仪及计算机可读存储介质 |
CN115711866A (zh) * | 2022-10-31 | 2023-02-24 | 西安电子科技大学 | 基于环形扫描照明的定量相衬层析显微装置和方法 |
WO2023125939A1 (zh) * | 2021-12-31 | 2023-07-06 | 深圳迈瑞生物医疗电子股份有限公司 | 血液细胞分析仪、提示感染状态的方法以及感染标志参数的用途 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102016004051B3 (de) | 2016-04-04 | 2017-07-27 | Technische Universität Dresden | Verfahren und Vorrichtung zur optischen in-ovo Geschlechtsbestimmung von befruchteten und bebrüteten Vogeleiern |
CN107655865B (zh) * | 2016-07-25 | 2021-10-19 | 希森美康株式会社 | 血液分析装置及血液分析方法 |
CN111781168B (zh) * | 2020-06-17 | 2023-06-13 | 迈克医疗电子有限公司 | 红细胞碎片识别区域的调整方法、装置、设备和介质 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060223137A1 (en) * | 2005-03-29 | 2006-10-05 | Sysmex Corporation | Reagent for partially lysing a cell membrane of a red blood cell, a reagent for detecting malaria infected red blood cells, and a sample analyzing method for detecting malaria infected red blood cells |
EP1746407A2 (en) * | 2005-07-21 | 2007-01-24 | Sysmex Corporation | Blood analyzing method and blood analyzer |
WO2009136570A1 (ja) * | 2008-05-09 | 2009-11-12 | シスメックス株式会社 | 血液分析装置、血液分析方法および溶血剤 |
CN102016573A (zh) * | 2008-05-09 | 2011-04-13 | 希森美康株式会社 | 血液分析装置,血液分析方法,溶血剂及染色剂 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5431732B2 (ja) * | 2005-12-29 | 2014-03-05 | ハネウェル・インターナショナル・インコーポレーテッド | マイクロ流体フォーマットにおけるアッセイ実装 |
US8842900B2 (en) * | 2008-10-28 | 2014-09-23 | Sysmex Corporation | Specimen processing system and blood cell image classifying apparatus |
CN102109430B (zh) | 2009-12-25 | 2013-11-06 | 深圳迈瑞生物医疗电子股份有限公司 | 有核红细胞模拟粒子,血液质控物及其制备方法和用途 |
-
2011
- 2011-10-31 CN CN201110337707.8A patent/CN103091286B/zh active Active
-
2012
- 2012-10-31 WO PCT/CN2012/083864 patent/WO2013064078A1/zh active Application Filing
- 2012-10-31 US US14/355,544 patent/US10656143B2/en active Active
-
2020
- 2020-03-10 US US16/814,846 patent/US20200209224A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060223137A1 (en) * | 2005-03-29 | 2006-10-05 | Sysmex Corporation | Reagent for partially lysing a cell membrane of a red blood cell, a reagent for detecting malaria infected red blood cells, and a sample analyzing method for detecting malaria infected red blood cells |
EP1746407A2 (en) * | 2005-07-21 | 2007-01-24 | Sysmex Corporation | Blood analyzing method and blood analyzer |
WO2009136570A1 (ja) * | 2008-05-09 | 2009-11-12 | シスメックス株式会社 | 血液分析装置、血液分析方法および溶血剤 |
CN102016573A (zh) * | 2008-05-09 | 2011-04-13 | 希森美康株式会社 | 血液分析装置,血液分析方法,溶血剂及染色剂 |
Non-Patent Citations (2)
Title |
---|
GERMAN C Z 等: "Design of Malaria Diagnostic Criteria for the Sysmex XE-2100Hematology Analyzer", 《THE AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE》 * |
未知: "第65届中国国际医疗器械春季博览会_CMEF_产品选介", 《中国医疗器械信息》 * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104297135A (zh) * | 2013-07-16 | 2015-01-21 | 成都深迈瑞医疗电子技术研究院有限公司 | 血液样本中粒子的识别方法、系统及血液细胞分析仪 |
CN104297135B (zh) * | 2013-07-16 | 2017-02-15 | 成都深迈瑞医疗电子技术研究院有限公司 | 血液样本中粒子的识别方法、系统及血液细胞分析仪 |
CN104422646B (zh) * | 2013-08-30 | 2018-07-13 | 希森美康株式会社 | 样本分析方法及样本分析装置 |
CN104422646A (zh) * | 2013-08-30 | 2015-03-18 | 希森美康株式会社 | 样本分析方法及样本分析装置 |
CN104515723A (zh) * | 2013-09-30 | 2015-04-15 | 深圳迈瑞生物医疗电子股份有限公司 | 细胞分析仪及其红细胞凝集报警方法和系统 |
US10241048B2 (en) | 2014-08-08 | 2019-03-26 | Sysmex Corporation | Blood analyzing method and blood analyzer |
CN105372216A (zh) * | 2014-08-08 | 2016-03-02 | 希森美康株式会社 | 血液分析方法及血液分析装置 |
CN110244032A (zh) * | 2015-02-12 | 2019-09-17 | 深圳迈瑞生物医疗电子股份有限公司 | 细胞分析仪及细胞分析仪的分类方法 |
CN106483109A (zh) * | 2015-08-31 | 2017-03-08 | 希森美康株式会社 | 血液分析装置及血液分析方法 |
CN106483109B (zh) * | 2015-08-31 | 2020-12-15 | 希森美康株式会社 | 血液分析装置及血液分析方法 |
CN108226127A (zh) * | 2017-12-26 | 2018-06-29 | 深圳国际旅行卫生保健中心 | 测定疟原虫含量的方法和检测疟原虫含量的系统 |
CN108226127B (zh) * | 2017-12-26 | 2021-04-06 | 深圳国际旅行卫生保健中心 | 测定疟原虫含量的方法和检测疟原虫含量的系统 |
CN109580550A (zh) * | 2018-12-03 | 2019-04-05 | 迪瑞医疗科技股份有限公司 | 一种白细胞的分类处理方法及其装置 |
CN113330311A (zh) * | 2019-12-31 | 2021-08-31 | 深圳迈瑞生物医疗电子股份有限公司 | 细胞图像分析装置和样本分析方法 |
WO2022115982A1 (zh) * | 2020-12-01 | 2022-06-09 | 深圳迈瑞生物医疗电子股份有限公司 | 样本分析方法、样本分析仪及计算机可读存储介质 |
WO2023125939A1 (zh) * | 2021-12-31 | 2023-07-06 | 深圳迈瑞生物医疗电子股份有限公司 | 血液细胞分析仪、提示感染状态的方法以及感染标志参数的用途 |
CN115711866A (zh) * | 2022-10-31 | 2023-02-24 | 西安电子科技大学 | 基于环形扫描照明的定量相衬层析显微装置和方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103091286B (zh) | 2016-08-17 |
WO2013064078A1 (zh) | 2013-05-10 |
US10656143B2 (en) | 2020-05-19 |
US20200209224A1 (en) | 2020-07-02 |
US20140308697A1 (en) | 2014-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103091286A (zh) | 疟原虫感染的红细胞的识别方法及装置 | |
US9588102B2 (en) | Method and apparatus for determining white blood cell counts | |
US10222320B2 (en) | Identifying and enumerating early granulated cells (EGCs) | |
JP6710512B2 (ja) | 血液分析装置、血液分析方法及びコンピュータプログラム | |
JP4911601B2 (ja) | 有核赤血球細胞の計測方法 | |
US20180196070A1 (en) | Immature platelet enumeration systems and methods | |
US20180003634A1 (en) | Nucleated red blood cell warning method and device, and flow cytometer using the same | |
JP5762523B2 (ja) | 血液サンプルを分析するための方法およびシステム | |
CN110383037B (zh) | 一种血小板聚集识别的方法、装置和细胞分析仪 | |
US20210123852A1 (en) | Methods and Systems for Sample Analysis | |
US20180321129A1 (en) | Method of detecting neutrophil extracellular traps | |
US8512977B2 (en) | Analyzing reticulocytes | |
Kickler | Clinical analyzers. Advances in automated cell counting | |
CN103620386A (zh) | 诊断血内寄生物的方法和设备 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180807 Address after: 518057 the 1-4 floor of MINDRAY building, science and technology south twelve Road, Nanshan District high tech Industrial Park, Shenzhen, Guangdong. Co-patentee after: SHENZHEN MINDRAY SCIENTIFIC Co.,Ltd. Patentee after: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS Co.,Ltd. Address before: 518057 MINDRAY science and technology south twelve road MINDRAY high tech Industrial Park, Shenzhen, Guangdong Patentee before: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130508 Assignee: Shenzhen Mindray Animal Medical Technology Co.,Ltd. Assignor: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS Co.,Ltd. Contract record no.: X2022440020009 Denomination of invention: Method and device for identifying red blood cells infected with Plasmodium Granted publication date: 20160817 License type: Common License Record date: 20220804 |